Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

Live Free Accredited Webinar!
August 26, 2021 - 6:00 PM & 8:00 PM ET

Faculty Presenter

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey

Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
 
Program Description
COVID-19 continues to be a global threat with limited treatment options. An effective vaccine has the potential to reduce the spread and associated mortality related to this virus. A COVID-19 vaccine development initiative is underway and is rapidly evolving as ongoing clinical trials provide insight into vaccine candidate safety and efficacy. Pharmacists should have a comprehensive knowledge of COVID-19 vaccines to effectively educate the public and address concerns. This webinar will provide pharmacists with an update on current development efforts for a COVID-19 vaccine.

Target Audience: Retail pharmacists
Type of Activity: Application
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Examine updates related to the public health burden of COVID-19
• Explore the currently available vaccines as well as the vaccines in development including updates related to clinical trial data
• Explain the role of the pharmacist in addressing patient concerns revolving around the COVID-19 vaccinations
   

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-289-L06-P. The activity is available for CE credit through October 26, 2021.

Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FNAP, has the following relevant financial relationship with a commercial interest to disclose:

Speakers Bureau: AstraZeneca

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD CHCP; Liz Rauh; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Activity Disclaimer
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this live CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms